Targeting TIM-3 for hematological malignancy: latest updates from the 2022 ASH annual meeting
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Targeting TIM-3 for hematological malignancy: latest updates from the 2022 ASH annual meeting ; volume:12 ; number:1 ; day:19 ; month:7 ; year:2023 ; pages:1-4 ; date:12.2023
Experimental hematology & oncology ; 12, Heft 1 (19.7.2023), 1-4, 12.2023
- Creator
-
Tan, Jiaxiong
Tan, Huo
Li, Yangqiu
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40164-023-00421-2
- URN
-
urn:nbn:de:101:1-2023102513024461818088
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tan, Jiaxiong
- Tan, Huo
- Li, Yangqiu
- SpringerLink (Online service)
Other Objects (12)
Dual-targeted CAR T-cell immunotherapies for hematological malignancies: latest updates from the 2023 ASH annual meeting
The role of BCL11B in hematological malignancy
Immunogenic Cell Death in Hematological Malignancy Therapy
Chryseobacterium indologenes: An emerging uropathogen among hematological malignancy patients
Management strategy for hematological malignancy patients with acute respiratory failure
Mosunetuzumab and lymphoma: latest updates from 2022 ASH annual meeting
HIV associated lymphoma: latest updates from 2023 ASH annual meeting
Differentiating central nervous system infection from disease infiltration in hematological malignancy
Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan
A Rare Occurrence of Solid Gynecological Malignancy Synchronous with Hematological Malignancy: Rare Case and Review of Literature
Pediatric hematological malignancy: Identification of issues involved in the road to diagnosis
CAR-NK cell therapy for hematological malignancies: recent updates from ASH 2022
Dual-targeted CAR T-cell immunotherapies for hematological malignancies: latest updates from the 2023 ASH annual meeting
The role of BCL11B in hematological malignancy
Immunogenic Cell Death in Hematological Malignancy Therapy
Chryseobacterium indologenes: An emerging uropathogen among hematological malignancy patients
Management strategy for hematological malignancy patients with acute respiratory failure
Mosunetuzumab and lymphoma: latest updates from 2022 ASH annual meeting
HIV associated lymphoma: latest updates from 2023 ASH annual meeting
Differentiating central nervous system infection from disease infiltration in hematological malignancy
Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan
A Rare Occurrence of Solid Gynecological Malignancy Synchronous with Hematological Malignancy: Rare Case and Review of Literature
Pediatric hematological malignancy: Identification of issues involved in the road to diagnosis
CAR-NK cell therapy for hematological malignancies: recent updates from ASH 2022
Dual-targeted CAR T-cell immunotherapies for hematological malignancies: latest updates from the 2023 ASH annual meeting
The role of BCL11B in hematological malignancy
Immunogenic Cell Death in Hematological Malignancy Therapy
Chryseobacterium indologenes: An emerging uropathogen among hematological malignancy patients
Management strategy for hematological malignancy patients with acute respiratory failure
Mosunetuzumab and lymphoma: latest updates from 2022 ASH annual meeting
HIV associated lymphoma: latest updates from 2023 ASH annual meeting
Differentiating central nervous system infection from disease infiltration in hematological malignancy
Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan
A Rare Occurrence of Solid Gynecological Malignancy Synchronous with Hematological Malignancy: Rare Case and Review of Literature
Pediatric hematological malignancy: Identification of issues involved in the road to diagnosis